Pfizer Stock Price Prediction

<div class='circular--portrait' style='background:#FF0F00;color: #FFFFF0;font-size:3em;padding-top: 38px;;'>PFE</div>
PFE -- USA Stock  

Report: 28th of July 2020  

Pfizer Inc stock price prediction is an act of determining the future value of Pfizer shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Pfizer stock future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Pfizer Inc, which may create opportunities for some arbitrage if properly timed. Please check Pfizer Basic Forecasting Models to cross-verify your projections.

Search Stock Price Prediction

It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Pfizer based on different types of headlines from major news networks to social media. The Pfizer stock price prediction module provides an analysis of price elasticity to changes in media outlook on Pfizer over a specific investment horizon. Using Pfizer hype-based prediction, you can estimate the value of Pfizer Inc from the perspective of Pfizer response to recently generated media hype and the effects of current headlines on its competitors. Pfizer Calculated Tax Rate is expected to decrease significantly based on the last few years of reporting. The past year's Calculated Tax Rate was at 7.83. The current year Inventory Turnover is expected to grow to 1.59, whereas PPandE Turnover is expected to decline to 3.59.
This module is based on analyzing investor sentiment around taking a position in Pfizer. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Pfizer to buy its stock at a price that has no basis in reality. In that case, they are not buying Pfizer because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Pfizer after-hype prediction price

There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Estimates (4)
LowProjected EPSHigh
LowReal ValueHigh
10 Analysts
LowTarget PriceHigh

Pfizer After-Hype Price Prediction Density Analysis

As far as predicting the price of Pfizer at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Pfizer or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many smart people who confused the symmetrical distributions of stock prices, such as prices of Pfizer, with the unreliable approximations that try to describe financial returns.
 Next price density 
      Expected price to next headline 

Pfizer Estimiated After-Hype Price Volatility

Current Value
9th of July 2020
After-hype Price
Pfizer is very steady asset. Analysis and calculation of next after-hype price of Pfizer Inc is based on 3 months time horizon.

Pfizer Stock Price Prediction Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.06  1.99  0.02   0.16  11 Events / Month3 Events / MonthIn about 11 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Pfizer Hype Timeline

On the 9th of July Pfizer Inc is traded for 33.47. The entity has historical hype elasticity of -0.02 and average elasticity to hype of competition of -0.16. Pfizer is projected to decline in value after the next headline with price expected to drop to 33.74. The average volatility of media hype impact on the company stock price is over 100%. The price depreciation on the next news is expected to be -0.03% whereas the daily expected return is at this time at -0.06%. The volatility of related hype on Pfizer is about 73.54% with expected price after next announcement by competition of 33.31. About 73.0% of the company shares are owned by institutional investors. The book value of Pfizer was at this time reported as 11.71. The company last dividend was issued on the 30th of July 2020. Pfizer Inc had 3:1 split on 1st of July 1999. Considering the 30-days investment horizon, the next projected press release will be in about 11 days.
Please check Pfizer Basic Forecasting Models to cross-verify your projections.

Pfizer Related Hype Analysis

At Risk
Pfizer Inc(0.27) 11 per month 2.14 (0.07)  2.87 (2.78)  10.99 
Immune Pharmaceuticals 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
Regeneron Pharmaceuticals(27.62) 9 per month 1.98  0.1  5.98 (3.63)  11.57 
Perrigo Company Plc 2.11 8 per month 1.57  0.09  3.79 (2.68)  11.72 
Dr Reddys Laboratories(0.16) 7 per month 1.32  0.09  4.76 (2.26)  11.58 
Sinovac Biotech 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
Allergan Plc 0.00 0 per month 0.00 (0.0425)  1.39 (0.55)  3.37 
PAREXEL International Corp 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
Zoetis Inc(2.08) 9 per month 2.14  0.06  3.83 (3.47)  16.95 
Vertex Pharmaceuticals Incorpor 0.96 11 per month 2.01  0.08  4.51 (3.81)  13.61 

Pfizer Additional Predictive Modules

Most predictive techniques to examine Pfizer stock price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Pfizer using various technical indicators. When you analyze Pfizer charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators
Math Operators
Math Transform
Momentum Indicators
Overlap Studies
Pattern Recognition
Price Transform
Statistic Functions
Volatility Indicators
Volume Indicators
MACD with controllable MA type
Williams R percentage
Money Flow Index
Plus Directional Indicator
Rate of change percentage
Plus Directional Movement
Chande Momentum Oscillator
Absolute Price Oscillator
Ultimate Oscillator

About Pfizer Predictive Indicators

The successful prediction of Pfizer stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Pfizer Inc, already reflect all publically available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'text-book' version of this hypothesis and continually tries to find mispriced stocks to increase returns on his or her portfolios. We use internally-developed statistical techniques to arrive at the intrinsic value of BlackBerry Limited based on analysis of Pfizer hews, social hype, and general headline patterns together with widely used predictive technical indicators. We also calculate exposure to Pfizer's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Pfizer's related companies.
 2017 2018 2019 2020 (projected)
Long Term Debt to Equity0.470.520.570.49
Interest Coverage14.6111.787.679.09
Please check Pfizer Basic Forecasting Models to cross-verify your projections. Please also try Money Flow Index module to determine momentum by analyzing money flow index and other technical indicators.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page